These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 16825275
1. Mycophenolate mofetil in the treatment of uveitis in children. Doycheva D, Deuter C, Stuebiger N, Biester S, Zierhut M. Br J Ophthalmol; 2007 Feb; 91(2):180-4. PubMed ID: 16825275 [Abstract] [Full Text] [Related]
2. Long-term results of therapy with mycophenolate mofetil in chronic non-infectious uveitis. Doycheva D, Zierhut M, Blumenstock G, Stuebiger N, Deuter C. Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1235-43. PubMed ID: 21720813 [Abstract] [Full Text] [Related]
3. Mycophenolate mofetil is a highly effective and safe immunosuppressive agent for the treatment of uveitis : a retrospective analysis of 106 patients. Siepmann K, Huber M, Stübiger N, Deuter C, Zierhut M. Graefes Arch Clin Exp Ophthalmol; 2006 Jul; 244(7):788-94. PubMed ID: 16163494 [Abstract] [Full Text] [Related]
4. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]. Greiner K, Varikkara M, Santiago C, Forrester JV. Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil for the treatment of uveitis. Teoh SC, Hogan AC, Dick AD, Lee RW. Am J Ophthalmol; 2008 Nov; 146(5):752-60, 760.e1-3. PubMed ID: 18455143 [Abstract] [Full Text] [Related]
7. Long-term efficacy of mycophenolate mofetil in the control of severe intraocular inflammation. Lau CH, Comer M, Lightman S. Clin Exp Ophthalmol; 2003 Dec; 31(6):487-91. PubMed ID: 14641155 [Abstract] [Full Text] [Related]
18. Mycophenolate mofetil in the treatment of chronic non-infectious, non-necrotizing scleritis. Kolomeyer AM, Ragam A, Shah K, Jachens AW, Tu Y, Chu DS. Ocul Immunol Inflamm; 2012 Apr; 20(2):113-8. PubMed ID: 22409564 [Abstract] [Full Text] [Related]
19. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report]. Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA. Przegl Lek; 2006 Apr; 63 Suppl 3():44-8. PubMed ID: 16898486 [Abstract] [Full Text] [Related]